Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP232903.RA3aqw99BPIPgX9EsI-89-5JPY8xIDdbJ6NZMkdcRARyA130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP232903.RA3aqw99BPIPgX9EsI-89-5JPY8xIDdbJ6NZMkdcRARyA130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP232903.RA3aqw99BPIPgX9EsI-89-5JPY8xIDdbJ6NZMkdcRARyA130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP232903.RA3aqw99BPIPgX9EsI-89-5JPY8xIDdbJ6NZMkdcRARyA130_provenance.
- NP232903.RA3aqw99BPIPgX9EsI-89-5JPY8xIDdbJ6NZMkdcRARyA130_assertion wasGeneratedBy ECO_0000203 NP232903.RA3aqw99BPIPgX9EsI-89-5JPY8xIDdbJ6NZMkdcRARyA130_provenance.
- NP232903.RA3aqw99BPIPgX9EsI-89-5JPY8xIDdbJ6NZMkdcRARyA130_assertion wasDerivedFrom befree-20140225 NP232903.RA3aqw99BPIPgX9EsI-89-5JPY8xIDdbJ6NZMkdcRARyA130_provenance.
- NP232903.RA3aqw99BPIPgX9EsI-89-5JPY8xIDdbJ6NZMkdcRARyA130_assertion SIO_000772 19605817 NP232903.RA3aqw99BPIPgX9EsI-89-5JPY8xIDdbJ6NZMkdcRARyA130_provenance.
- NP232903.RA3aqw99BPIPgX9EsI-89-5JPY8xIDdbJ6NZMkdcRARyA130_assertion evidence source_evidence_literature NP232903.RA3aqw99BPIPgX9EsI-89-5JPY8xIDdbJ6NZMkdcRARyA130_provenance.
- NP232903.RA3aqw99BPIPgX9EsI-89-5JPY8xIDdbJ6NZMkdcRARyA130_assertion description "[For tumors with chromosome 17 polysomy, when using the manufacturers' criteria, the concordance values between CISH and FISH at site A, site B, and intersite CISH agreement were 95.8%, 95.5%, and 93.5%, respectively; when using the American Society of Clinical Oncology/College of American Pathologists (ASCO/CAP) criteria, the values were 100.0%, 100.0%, and 100.0%, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP232903.RA3aqw99BPIPgX9EsI-89-5JPY8xIDdbJ6NZMkdcRARyA130_provenance.
- befree-20140225 importedOn "2014-02-25" NP232903.RA3aqw99BPIPgX9EsI-89-5JPY8xIDdbJ6NZMkdcRARyA130_provenance.